
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Sec61α1 CRISPR/Cas9 KO Plasmid (m) | sc-424716 | 20 µg | $397.00 |
Sec61a1 encodes Sec61α1, the pore-forming core subunit of the Sec61 translocon in the endoplasmic reticulum (ER) membrane that mediates co-translational and post-translational import of secretory and membrane proteins. By coupling ribosome docking with peptide translocation and integration, Sec61α1 supports protein biogenesis, ER quality control, and proteostasis pathways including unfolded protein response signaling and ER-associated degradation. Perturbation of SEC61 channel function has been linked to defects in secretory pathway homeostasis and cellular stress responses, processes frequently implicated in inflammation, metabolic dysfunction, and neurodegeneration models. In mouse systems, Sec61a1 provides a tractable entry point to study how ER import capacity shapes signaling, differentiation, and survival under proteotoxic stress.
Sec61α1 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Sec61a1 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Sec61a1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Sec61a1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Sec61α1 protein expression.
This CRISPR knockout system enables efficient generation of Sec61a1-deficient cell models for investigation of Sec61α1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.